Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL. [electronic resource]
Producer: 20171229Description: 756-65 p. digitalISSN:- 1473-5741
- Antineoplastic Agents -- pharmacology
- Azepines -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Down-Regulation -- drug effects
- Gene Expression Regulation, Neoplastic
- Heterocyclic Compounds, 4 or More Rings -- pharmacology
- Humans
- Molecular Targeted Therapy -- methods
- Multiple Myeloma -- drug therapy
- N-Myc Proto-Oncogene Protein -- metabolism
- Protein Domains
- Proto-Oncogene Proteins c-myc -- genetics
- Triazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.